With respect to pricing and purchasing strategies, work has focused on non-regulated business management approaches such as price negotiations, and some provinces are exploring opportunities for multilateral buying groups. Also, the federal Competition Bureau undertook a study to examine the potential causes for the relatively high prices of generic drugs and how to make the markets work better.
On April 17th, 2008. See this statement in context.